Get the Daily Brief
Latest Biotech News
Pfizer and Trump Unveil Drug Pricing Deal Amid Tariff Controversy
Pfizer and the White House announced a drug pricing agreement featuring a direct-to-consumer platform named TrumpRX, aimed at lowering U.S. drug costs by offering medications at average discounts...
Innovations in Radiotherapy: Advances in Cancer and Cardiac Treatments
Pivotal clinical trials and studies have highlighted advances in radiation therapy across multiple indications. Key findings show that pulsed low-dose-rate chemoradiation effectively reduces side...
AI and Machine Learning Propel Breakthroughs in Drug Discovery and Cancer Diagnostics
Artificial intelligence is playing an increasing role in biotechnology, enhancing drug discovery and clinical diagnostics. Cadence launched ROCS X, an AI-powered virtual screening platform...
CRISPR Evolution and Novel Gene Editing Advances Uncovered
Recent studies have decoded the evolutionary origins and expanding capabilities of CRISPR systems, underpinning revolutionary gene editing applications. Research tracing Type V CRISPR-Cas systems...
Emerging Drug Approvals and Clinical Trial Milestones
Key regulatory approvals and clinical successes are shaping the biotech landscape. The FDA approved Novartis’ BTK inhibitor remibrutinib for chronic spontaneous urticaria, expanding therapeutic...
Innovations in Immunotherapy and Cancer Biology
Groundbreaking research is expanding the frontiers of immunotherapy and molecular oncology. Novel bispecific antibodies targeting tumor-specific antigens, such as EGFRxLGR5, show therapeutic...
Advancements in Genomic and Molecular Diagnostic Technologies
Significant progress has been made in genomic diagnostics and biomarker identification to support personalized medicine. SumHealth partnered with Nucleus Genomics to broaden access to whole-genome...
FDA and Biopharma Sector React to Looming US Government Shutdown
The potential shutdown of the U.S. federal government threatens to furlough or terminate approximately 41% of the Department of Health and Human Services staff, compounding the impact of prior...
Mental Health and Patient Engagement Metrics Gain Focus in Pharma Industry
Healthcare leaders underscore the critical role of robust metrics in designing and evaluating patient engagement programs, aiming to improve therapy adherence and outcomes. Executives from Acadia...
Pfizer’s Obesity Play: Metsera’s GLP-1 Drug Shows 14% Weight Loss, Questionable Side Effects
Metsera announced interim Phase 2 results for its obesity drug MET-097i demonstrating an average placebo-adjusted body weight reduction of approximately 14% at 28 weeks, paralleling Lilly’s...
Genmab Acquires Merus in $8B Deal to Advance Head and Neck Cancer Bispecific Antibody
Danish biotech Genmab is acquiring Netherland-based Merus for approximately $8 billion in an all-cash transaction, aiming to fully own Merus’ late-stage bispecific antibody petosemtamab, a...
CRISPR’s Evolution: RNA Splitting Mechanism Traced to Type V System Origins
A collaborative team led by Caixia Gao at the Chinese Academy of Sciences revealed the evolutionary origin of Type V CRISPR-Cas systems through the discovery of transposon-CRISPR intermediates...
Advanced AI Differentiates Glioblastoma During Surgery for Real-Time Diagnosis
Harvard Medical School researchers developed an artificial intelligence tool capable of real-time differentiation between glioblastoma and mimicking brain tumors during surgical procedures. This...
UniQure’s Gene Therapy Slows Huntington’s Disease Progression by 75% in 36-Month Data
UniQure reported compelling 36-month clinical data showing its gene therapy candidate AMT-130 significantly slowed Huntington’s disease progression—meeting the primary endpoint with a 75%...
Polymyxin B Antibiotic Kills Bacteria Only When Cells Are Metabolically Active
A University College London-led research team elucidated the mechanism behind polymyxin B’s bactericidal action, revealing it disrupts bacterial outer membranes in an energy-dependent manner....
NeuroKaire Launches Precision Depression Test Using Stem Cell-Derived Neurons
Israeli firm NeuroKaire has commercialized a laboratory-developed test that assesses major depressive disorder through analysis of patient-derived frontal cortical neurons differentiated from...
PHIL Launches Direct-to-Patient Platform to Enhance Access and Affordability in Pharma
PHIL unveiled its direct-to-patient 2.0 platform designed to improve pharmaceutical access and adherence by integrating coverage-first workflows, telemedicine, prescription fulfillment, real-time...
STAT+: FDA’s Top Regulator Criticizes Voclosporin Safety on LinkedIn
George Tidmarsh, the director of FDA’s Center for Drug Evaluation and Research, publicly questioned the safety and clinical benefit of voclosporin, a 2021-approved drug for lupus nephritis, on his...
Long-Term PSA Screening Boosts Early Prostate Cancer Detection and Outcomes
A 12-year cohort study in Korea involving over 5,400 prostate cancer patients demonstrated that sustained prostate-specific antigen (PSA) screening leads to earlier cancer detection and lowers...
Genmab’s $8B Merus Acquisition Fuels Cancer Pipeline Expansion
Danish biopharma Genmab is acquiring Dutch biotech Merus for approximately $8 billion in cash to gain full ownership of Merus’ late-stage cancer assets, including the bispecific antibody...